Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Immuno-Cell Therapy Market Size Analysis from 2022 to 2027

1.5.1 Global Immuno-Cell Therapy Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Immuno-Cell Therapy Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Immuno-Cell Therapy Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Immuno-Cell Therapy Industry Impact

Chapter 2 Global Immuno-Cell Therapy Competition by Types, Applications, and Top Regions and Countries

2.1 Global Immuno-Cell Therapy (Volume and Value) by Type

2.1.1 Global Immuno-Cell Therapy Consumption and Market Share by Type (2016-2021)

2.1.2 Global Immuno-Cell Therapy Revenue and Market Share by Type (2016-2021)

2.2 Global Immuno-Cell Therapy (Volume and Value) by Application

2.2.1 Global Immuno-Cell Therapy Consumption and Market Share by Application (2016-2021)

2.2.2 Global Immuno-Cell Therapy Revenue and Market Share by Application (2016-2021)

2.3 Global Immuno-Cell Therapy (Volume and Value) by Regions

2.3.1 Global Immuno-Cell Therapy Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Immuno-Cell Therapy Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Immuno-Cell Therapy Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Immuno-Cell Therapy Consumption by Regions (2016-2021)

4.2 North America Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

4.10 South America Immuno-Cell Therapy Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Immuno-Cell Therapy Market Analysis

5.1 North America Immuno-Cell Therapy Consumption and Value Analysis

5.1.1 North America Immuno-Cell Therapy Market Under COVID-19

5.2 North America Immuno-Cell Therapy Consumption Volume by Types

5.3 North America Immuno-Cell Therapy Consumption Structure by Application

5.4 North America Immuno-Cell Therapy Consumption by Top Countries

5.4.1 United States Immuno-Cell Therapy Consumption Volume from 2016 to 2021

5.4.2 Canada Immuno-Cell Therapy Consumption Volume from 2016 to 2021

5.4.3 Mexico Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 6 East Asia Immuno-Cell Therapy Market Analysis

6.1 East Asia Immuno-Cell Therapy Consumption and Value Analysis

6.1.1 East Asia Immuno-Cell Therapy Market Under COVID-19

6.2 East Asia Immuno-Cell Therapy Consumption Volume by Types

6.3 East Asia Immuno-Cell Therapy Consumption Structure by Application

6.4 East Asia Immuno-Cell Therapy Consumption by Top Countries

6.4.1 China Immuno-Cell Therapy Consumption Volume from 2016 to 2021

6.4.2 Japan Immuno-Cell Therapy Consumption Volume from 2016 to 2021

6.4.3 South Korea Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 7 Europe Immuno-Cell Therapy Market Analysis

7.1 Europe Immuno-Cell Therapy Consumption and Value Analysis

7.1.1 Europe Immuno-Cell Therapy Market Under COVID-19

7.2 Europe Immuno-Cell Therapy Consumption Volume by Types

7.3 Europe Immuno-Cell Therapy Consumption Structure by Application

7.4 Europe Immuno-Cell Therapy Consumption by Top Countries

7.4.1 Germany Immuno-Cell Therapy Consumption Volume from 2016 to 2021

7.4.2 UK Immuno-Cell Therapy Consumption Volume from 2016 to 2021

7.4.3 France Immuno-Cell Therapy Consumption Volume from 2016 to 2021

7.4.4 Italy Immuno-Cell Therapy Consumption Volume from 2016 to 2021

7.4.5 Russia Immuno-Cell Therapy Consumption Volume from 2016 to 2021

7.4.6 Spain Immuno-Cell Therapy Consumption Volume from 2016 to 2021

7.4.7 Netherlands Immuno-Cell Therapy Consumption Volume from 2016 to 2021

7.4.8 Switzerland Immuno-Cell Therapy Consumption Volume from 2016 to 2021

7.4.9 Poland Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 8 South Asia Immuno-Cell Therapy Market Analysis

8.1 South Asia Immuno-Cell Therapy Consumption and Value Analysis

8.1.1 South Asia Immuno-Cell Therapy Market Under COVID-19

8.2 South Asia Immuno-Cell Therapy Consumption Volume by Types

8.3 South Asia Immuno-Cell Therapy Consumption Structure by Application

8.4 South Asia Immuno-Cell Therapy Consumption by Top Countries

8.4.1 India Immuno-Cell Therapy Consumption Volume from 2016 to 2021

8.4.2 Pakistan Immuno-Cell Therapy Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Immuno-Cell Therapy Market Analysis

9.1 Southeast Asia Immuno-Cell Therapy Consumption and Value Analysis

9.1.1 Southeast Asia Immuno-Cell Therapy Market Under COVID-19

9.2 Southeast Asia Immuno-Cell Therapy Consumption Volume by Types

9.3 Southeast Asia Immuno-Cell Therapy Consumption Structure by Application

9.4 Southeast Asia Immuno-Cell Therapy Consumption by Top Countries

9.4.1 Indonesia Immuno-Cell Therapy Consumption Volume from 2016 to 2021

9.4.2 Thailand Immuno-Cell Therapy Consumption Volume from 2016 to 2021

9.4.3 Singapore Immuno-Cell Therapy Consumption Volume from 2016 to 2021

9.4.4 Malaysia Immuno-Cell Therapy Consumption Volume from 2016 to 2021

9.4.5 Philippines Immuno-Cell Therapy Consumption Volume from 2016 to 2021

9.4.6 Vietnam Immuno-Cell Therapy Consumption Volume from 2016 to 2021

9.4.7 Myanmar Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 10 Middle East Immuno-Cell Therapy Market Analysis

10.1 Middle East Immuno-Cell Therapy Consumption and Value Analysis

10.1.1 Middle East Immuno-Cell Therapy Market Under COVID-19

10.2 Middle East Immuno-Cell Therapy Consumption Volume by Types

10.3 Middle East Immuno-Cell Therapy Consumption Structure by Application

10.4 Middle East Immuno-Cell Therapy Consumption by Top Countries

10.4.1 Turkey Immuno-Cell Therapy Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Immuno-Cell Therapy Consumption Volume from 2016 to 2021

10.4.3 Iran Immuno-Cell Therapy Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Immuno-Cell Therapy Consumption Volume from 2016 to 2021

10.4.5 Israel Immuno-Cell Therapy Consumption Volume from 2016 to 2021

10.4.6 Iraq Immuno-Cell Therapy Consumption Volume from 2016 to 2021

10.4.7 Qatar Immuno-Cell Therapy Consumption Volume from 2016 to 2021

10.4.8 Kuwait Immuno-Cell Therapy Consumption Volume from 2016 to 2021

10.4.9 Oman Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 11 Africa Immuno-Cell Therapy Market Analysis

11.1 Africa Immuno-Cell Therapy Consumption and Value Analysis

11.1.1 Africa Immuno-Cell Therapy Market Under COVID-19

11.2 Africa Immuno-Cell Therapy Consumption Volume by Types

11.3 Africa Immuno-Cell Therapy Consumption Structure by Application

11.4 Africa Immuno-Cell Therapy Consumption by Top Countries

11.4.1 Nigeria Immuno-Cell Therapy Consumption Volume from 2016 to 2021

11.4.2 South Africa Immuno-Cell Therapy Consumption Volume from 2016 to 2021

11.4.3 Egypt Immuno-Cell Therapy Consumption Volume from 2016 to 2021

11.4.4 Algeria Immuno-Cell Therapy Consumption Volume from 2016 to 2021

11.4.5 Morocco Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 12 Oceania Immuno-Cell Therapy Market Analysis

12.1 Oceania Immuno-Cell Therapy Consumption and Value Analysis

12.2 Oceania Immuno-Cell Therapy Consumption Volume by Types

12.3 Oceania Immuno-Cell Therapy Consumption Structure by Application

12.4 Oceania Immuno-Cell Therapy Consumption by Top Countries

12.4.1 Australia Immuno-Cell Therapy Consumption Volume from 2016 to 2021

12.4.2 New Zealand Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 13 South America Immuno-Cell Therapy Market Analysis

13.1 South America Immuno-Cell Therapy Consumption and Value Analysis

13.1.1 South America Immuno-Cell Therapy Market Under COVID-19

13.2 South America Immuno-Cell Therapy Consumption Volume by Types

13.3 South America Immuno-Cell Therapy Consumption Structure by Application

13.4 South America Immuno-Cell Therapy Consumption Volume by Major Countries

13.4.1 Brazil Immuno-Cell Therapy Consumption Volume from 2016 to 2021

13.4.2 Argentina Immuno-Cell Therapy Consumption Volume from 2016 to 2021

13.4.3 Columbia Immuno-Cell Therapy Consumption Volume from 2016 to 2021

13.4.4 Chile Immuno-Cell Therapy Consumption Volume from 2016 to 2021

13.4.5 Venezuela Immuno-Cell Therapy Consumption Volume from 2016 to 2021

13.4.6 Peru Immuno-Cell Therapy Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Immuno-Cell Therapy Consumption Volume from 2016 to 2021

13.4.8 Ecuador Immuno-Cell Therapy Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Immuno-Cell Therapy Business

14.1 MEDINET Co

14.1.1 MEDINET Co Company Profile

14.1.2 MEDINET Co Immuno-Cell Therapy Product Specification

14.1.3 MEDINET Co Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Gilead Sciences

14.2.1 Gilead Sciences Company Profile

14.2.2 Gilead Sciences Immuno-Cell Therapy Product Specification

14.2.3 Gilead Sciences Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Takeda

14.3.1 Takeda Company Profile

14.3.2 Takeda Immuno-Cell Therapy Product Specification

14.3.3 Takeda Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Erytech

14.4.1 Erytech Company Profile

14.4.2 Erytech Immuno-Cell Therapy Product Specification

14.4.3 Erytech Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Fate Therapeutics

14.5.1 Fate Therapeutics Company Profile

14.5.2 Fate Therapeutics Immuno-Cell Therapy Product Specification

14.5.3 Fate Therapeutics Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Seta Clinic Group

14.6.1 Seta Clinic Group Company Profile

14.6.2 Seta Clinic Group Immuno-Cell Therapy Product Specification

14.6.3 Seta Clinic Group Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Osiris

14.7.1 Osiris Company Profile

14.7.2 Osiris Immuno-Cell Therapy Product Specification

14.7.3 Osiris Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Oxford BioTherapeutics

14.8.1 Oxford BioTherapeutics Company Profile

14.8.2 Oxford BioTherapeutics Immuno-Cell Therapy Product Specification

14.8.3 Oxford BioTherapeutics Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 SBI Holdings

14.9.1 SBI Holdings Company Profile

14.9.2 SBI Holdings Immuno-Cell Therapy Product Specification

14.9.3 SBI Holdings Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Novartis

14.10.1 Novartis Company Profile

14.10.2 Novartis Immuno-Cell Therapy Product Specification

14.10.3 Novartis Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Golden Meditech

14.11.1 Golden Meditech Company Profile

14.11.2 Golden Meditech Immuno-Cell Therapy Product Specification

14.11.3 Golden Meditech Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Vericel Corporation

14.12.1 Vericel Corporation Company Profile

14.12.2 Vericel Corporation Immuno-Cell Therapy Product Specification

14.12.3 Vericel Corporation Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Guanhao Biotech

14.13.1 Guanhao Biotech Company Profile

14.13.2 Guanhao Biotech Immuno-Cell Therapy Product Specification

14.13.3 Guanhao Biotech Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Beike Biotechnology

14.14.1 Beike Biotechnology Company Profile

14.14.2 Beike Biotechnology Immuno-Cell Therapy Product Specification

14.14.3 Beike Biotechnology Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.15 Fujifilm Cellular Dynamics

14.15.1 Fujifilm Cellular Dynamics Company Profile

14.15.2 Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Specification

14.15.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.16 Beroni Group

14.16.1 Beroni Group Company Profile

14.16.2 Beroni Group Immuno-Cell Therapy Product Specification

14.16.3 Beroni Group Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.17 JCR Pharmaceuticals

14.17.1 JCR Pharmaceuticals Company Profile

14.17.2 JCR Pharmaceuticals Immuno-Cell Therapy Product Specification

14.17.3 JCR Pharmaceuticals Immuno-Cell Therapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Immuno-Cell Therapy Market Forecast (2022-2027)

15.1 Global Immuno-Cell Therapy Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Immuno-Cell Therapy Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Immuno-Cell Therapy Value and Growth Rate Forecast (2022-2027)

15.2 Global Immuno-Cell Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Immuno-Cell Therapy Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Immuno-Cell Therapy Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Immuno-Cell Therapy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Immuno-Cell Therapy Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Immuno-Cell Therapy Consumption Forecast by Type (2022-2027)

15.3.2 Global Immuno-Cell Therapy Revenue Forecast by Type (2022-2027)

15.3.3 Global Immuno-Cell Therapy Price Forecast by Type (2022-2027)

15.4 Global Immuno-Cell Therapy Consumption Volume Forecast by Application (2022-2027)

15.5 Immuno-Cell Therapy Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology